Report #2859469

Received Sep 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: PA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

Administered in same limb as Hep B immune globulin; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of vaccine administered at inappropriate site in a patient who received HBV (Engerix B) for prophylaxis. On an unknown date, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced vaccine administered at inappropriate site (Verbatim: Administered in same limb as Hep B immune globulin). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 29-AUG-2025 There was an inquiry regarding the need to readminister Energix-B vaccine to a newborn who was given the vaccine in the same limb as Hep B immune globulin asking if they should readminister the vaccine. The reporter wanted to know if company has any guidance or recommendations for this.